All Posts Tagged With: "restated earnings"

Valeant Shares Slide After Company Forecasts Cut

Valeant Pharmaceuticals International Inc. (NYSE:VRX) shares plummeted Tuesday as new Chief Executive Officer Joseph Papa reduced the company‚Äôs 2016 earnings and sales forecasts. The earnings forecast for this year has been reduced to $6.60 to $7 a share, excluding some items, from the $8.50 to $9.50 a share anticipated by Valeant back in March. Analysts […]